Animal Models for Medication Development and Application to Treat Fetal Alcohol Effects.

Area of Science:

• Neuroscience
• Pharmacology
• Developmental Biology

Background:

• Ethanol consumption during pregnancy leads to lifelong consequences for offspring, families, and society.
• Fetal alcohol spectrum disorders (FASD) encompass physical and behavioral effects, primarily due to ethanol's impact on the developing central nervous system (CNS).
• Currently, no FDA-approved drugs are available to prevent, reduce, or treat FASD symptoms.

Purpose of the Study:

• To review promising intervention targets for FASD.
• To discuss past and ongoing efforts in developing pharmacological treatments for prenatal ethanol exposure effects.
• To highlight research aimed at reducing neurotoxic effects on the developing CNS and treating resulting behavioral impairments.

Main Methods:

• Review of preclinical research, primarily from rodent models.
• Analysis of ongoing screening and development of pharmacological treatments.
• Identification of promising intervention targets for FASD.

Main Results:

• Several promising research avenues exist in rodent models for reducing ethanol's neurotoxic effects and treating behavioral impairments.
• These preclinical findings have not yet advanced to clinical testing in humans.
• The review identifies key targets for future intervention strategies.

Conclusions:

• Pharmacological interventions show potential for mitigating the effects of prenatal ethanol exposure.
• Further research and clinical trials are necessary to translate promising preclinical findings into effective treatments for FASD.
• Developing treatments for FASD remains a critical unmet medical need.